Retrospective Study on CO 2 Laser for Second‐Line Treatment of Vulvar Lichen Sclerosus
Journal of Obstetrics and Gynaecology Research · 2025-10 · 51 (10)
DOI: 10.1111/jog.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 30.09.2025. Verfasst von Gian Piero Siliquini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology and Obstetrics Unit, Sedes Sapientiae Institute, Turin, Italy. Hauptthemen laut MEDLINE: Lasers, Gas, Vulvar Lichen Sclerosus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vulvar Lichen Sclerosus (VLS) represents a persistent inflammatory disease of the skin that particularly affects the genital area.
Aim
The study purpose was to investigate the effectiveness of CO 2 laser as a treatment of recalcitrant VLS. The parameters examined included treatment tolerance, patient satisfaction, symptoms, and VLS clinical markers.
Methods
This retrospective study enrolled 85 adult women affected by Vulvar Lichen Sclerosus (VLS), refractory to local corticosteroids. Patients were treated with three sessions of fractional CO 2 laser treatment at 4‐week intervals. For vulvovaginal treatment, a device with a scanning handpiece and dedicated probes was used. The effectiveness of the treatment was evaluated at 1 month follow up (T1) and at 6 months follow up (T2) from the last treatment session. The Vulvar Health Index (VuHI) and the Vaginal Health Index score (VHI) were used. Patients assessed the severity of their symptoms (dyspareunia and dryness specifically) using the Visual Analogue Scale (VAS), a 10‐point scale going from 0 (no symptoms) to 10 (maximum symptoms).
Results
VuHI showed significant improvement after completion of treatment compared to baseline ( p < 0.001). VHI showed significant improvement after completion of treatment compared to baseline ( p < 0.001). There was clear improvement, compared to baseline values, in the VAS score for superficial dyspareunia and for vulvar dryness.
Conclusion
Overall, the results of this study demonstrated that treatment of recalcitrant VLS with fractional CO 2 laser improved both clinical assessment and symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology and Obstetrics Unit, Sedes Sapientiae Institute, Turin, Italy.
- Gynecology and Obstetrics Unit, Mauriziano Umberto I Hospital, Department of Surgical Sciences, University of Turin, Turin, Italy.
- El.En. Group, Clinical Research & Practice Department, Calenzano, Italy.
- Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
ORCID-Profile: Irene Fusco
Zitieren
APA
Siliquini, G. P., Giorgi, M., Strano, C., Accomasso, F., Pennati, B. M., Fusco, I., Zingoni, T., Bert, F., & Bounous, V. E. (2025). Retrospective Study on CO 2 Laser for Second‐Line Treatment of Vulvar Lichen Sclerosus. Journal of Obstetrics and Gynaecology Research, 51(10). https://doi.org/10.1111/jog.70098
Vancouver
Siliquini GP, Giorgi M, Strano C, Accomasso F, Pennati BM, Fusco I, et al. Retrospective Study on CO 2 Laser for Second‐Line Treatment of Vulvar Lichen Sclerosus. Journal of Obstetrics and Gynaecology Research. 2025;51(10). doi:10.1111/jog.70098
BibTeX
@article{Siliquini2025,
author = {Siliquini, Gian Piero and Giorgi, Margherita and Strano, Concetta and Accomasso, Francesca and Pennati, Beatrice Marina and Fusco, Irene and Zingoni, Tiziano and Bert, Fabrizio and Bounous, Valentina Elisabetta},
title = {Retrospective Study on CO 2 Laser for Second‐Line Treatment of Vulvar Lichen Sclerosus},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
volume = {51},
number = {10},
doi = {10.1111/jog.70098}
}
EUVIMED